An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes

Diagnostic Microbiology and Infectious Disease

Volumn 62, Issue 2, 2008, Pages 205-209

  Yan, S Steve ^a   Schreckenberger, Paul C ^b   Zheng, Xiaotian ^c   Nelson, Nancy A ^d   Harrington, Susan M ^d   Tjhio, Joyce ^b   Fedorko, Daniel P ^d  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Fluoroquinolones; M emm type; Pediatric isolates; Point mutation; Resistance; Streptococcus pyogenes

Indexed keywords

AMINO ACID; CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE;

ARTICLE; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; HUMAN; PEDIATRIC HOSPITAL; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCREENING; SEQUENCE ANALYSIS; STREPTOCOCCUS PYOGENES; UNITED STATES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHICAGO; CHILD; CHILD, PRESCHOOL; DISK DIFFUSION ANTIMICROBIAL TESTS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FLUOROQUINOLONES; HOSPITALS, PEDIATRIC; HUMANS; INFANT; POINT MUTATION; PREVALENCE; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 51649108504     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.04.018     Document Type: Article

References (15)

1. Alberti S., Cortes G., Garcia-Rey C., Rubio C., Basquero F., Garcia-Rodriguez J.A., Bouza E., and Aguilar L. Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity. Antimicrob. Agents Chemother. 49 (2005) 418-420
2. Alberti S., Garcia-Rey C., Dominguez M.A., Aguilar L., Cercenado E., Gobernado M., Garcia-Perea A., and Spanish Surveillance Group for Respiratory Pathogens. Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility. J. Clin. Microbiol. 41 (2003) 2385-2390
3. Alonso R., Galimand M., and Courvalin P. parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513. Antimicrob. Agents Chemother. 46 (2002) 3686-3687
4. Alonso R., Mateo E., Galimand M., Garaizar J., Courvalin P., and Cisterna R. Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes. J. Clin. Microbiol. 43 (2005) 2492-2493
5. Billal D.S., Fedorko D.P., Yan S.S., Hotomi M., Fujihara K., Nelson N., and Yamanaka N. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types. J. Antimicrob. Chemother. 59 (2007) 28-34
6. Boos M., Mayer S., Fischer A., Köhrer K., Scheuring S., Heisig P., Verhoef J., Fluit A.C., and Schmitz F.J. In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Antimicrob. Agents Chemother. 45 (2001) 938-942
7. Creti R., Imperi M., Baldassarri L., Pataracchia M., Recchia S., Alfarone G., and Orefici G. emm types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years?. J. Clin. Microbiol. 45 (2007) 2249-2256
8. Janoir C., Zeller V., Kitzis M.D., Moreau N.J., and Gutmann L. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob. Agents Chemother. 40 (1996) 2760-2764
9. Malhotra-Kumar S., Lammens C., Chapelle S., Mallentjer C., Weyler J., and Goossens H. Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes. J. Antimicrob. Chemother. 55 (2005) 320-325
10. Orscheln R.C., Johnson D.R., Olson S.M., Presti R.M., Martin J.M., Kaplan E.L., and Storch G.A. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. J. Infect. Dis. 191 (2005) 1272-1279
11. Pérez-Trallero E., Fernández-Mazarrasa C., Garcia-Rey C., Bouza E., Aguilar L., Garcia-de-Lomas J., Baquero F., and Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob. Agents Chemother. 45 (2001) 3334-3340
12. Reinert R.R., Lutticken R., and Al-Lahham A. High-level fluoroquinolone resistance in a clinical Streptococcus pyogenes isolate in Germany. Clin. Microbiol. Infect. 10 (2004) 659-662
13. Richter S.S., Diekema D.J., Heilmann K.P., Almer L.S., Shortridge V.D., Zeitler R., Flamm R.K., and Doern G.V. Fluoroquinolone resistance in Streptococcus pyogenes. Clin. Infect. Dis. 36 (2003) 380-383
14. Yan S.S., Fedorko D.P., Fukuda C.D., and Gill V.J. Single point mutations in the quinolone resistance-determining regions of gyrA and parC genes of Streptococcus pyogenes are responsible for resistance to some fluoroquinolone antibiotics. 100th General Meeting of American Society for Microbiology. Los Angeles, CA (2000)
15. Yan S.S., Fox M.L., Holland S.M., Stock F., Gill V.J., and Fedorko D.P. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob. Agents Chemother. 44 (2000) 3196-3198